advertisement
Denis P 12
Showing records 1 to 12 |
Display all abstracts from Denis P116838 Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucomaCordeiro MF
Current Medical Research and Opinion 2024; 40: 647-655
118339 Two-Year Performance and Safety Results of the MINIject Supraciliary Implant in Patients With Primary Open-Angle Glaucoma: Meta-Analysis of the STAR-I, II, III TrialsDick HB
American Journal of Ophthalmology 2024; 260: 172-181
116838 Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucomaDenis P
Current Medical Research and Opinion 2024; 40: 647-655
118339 Two-Year Performance and Safety Results of the MINIject Supraciliary Implant in Patients With Primary Open-Angle Glaucoma: Meta-Analysis of the STAR-I, II, III TrialsMackert MJ
American Journal of Ophthalmology 2024; 260: 172-181
116838 Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucomaAstarita C
Current Medical Research and Opinion 2024; 40: 647-655
118339 Two-Year Performance and Safety Results of the MINIject Supraciliary Implant in Patients With Primary Open-Angle Glaucoma: Meta-Analysis of the STAR-I, II, III TrialsAhmed IIK
American Journal of Ophthalmology 2024; 260: 172-181
116838 Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucomaBelsey J
Current Medical Research and Opinion 2024; 40: 647-655
118339 Two-Year Performance and Safety Results of the MINIject Supraciliary Implant in Patients With Primary Open-Angle Glaucoma: Meta-Analysis of the STAR-I, II, III TrialsDenis P
American Journal of Ophthalmology 2024; 260: 172-181
116838 Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucomaRivas M
Current Medical Research and Opinion 2024; 40: 647-655
118339 Two-Year Performance and Safety Results of the MINIject Supraciliary Implant in Patients With Primary Open-Angle Glaucoma: Meta-Analysis of the STAR-I, II, III TrialsHirneiß C
American Journal of Ophthalmology 2024; 260: 172-181
116838 Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucomaGarcía-Feijoo J
Current Medical Research and Opinion 2024; 40: 647-655
118339 Two-Year Performance and Safety Results of the MINIject Supraciliary Implant in Patients With Primary Open-Angle Glaucoma: Meta-Analysis of the STAR-I, II, III TrialsFlowers BE; Singh IP; Mansouri K; Fea AM
American Journal of Ophthalmology 2024; 260: 172-181